IBS patients respond differently to placebo analgesic, study says

06/4/2014 | Medscape (free registration)

Irritable bowel syndrome patients undergoing painful stimuli were less able to down-regulate the pain when given a placebo analgesic, compared with healthy people and ulcerative colitis patients in remission, German researchers reported. The study also showed that IBS patients who had greater levels of depressive symptoms had a weaker response to placebo analgesia. Interest in placebo analgesia was sparked by a 2008 study that suggested placebo acupuncture was effective in IBS.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ